Menu Close

Trending

Merck makes circular RNA play with $3.5bn Orna alliance
On heels of new data, Gilead pays $455m for Asian Trodelvy rights
Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy
Digital health’s rapid growth spurt comes home to roost
FDA grants swift review to Lynparza in first-line prostate cancer

Insights

Cytel_feature-image

Insights/ R&D/ Slider in whitepapers/ White Papers/ Whitepapers

How to craft responsive clinical trials that are designed for success

, , 0 Comment

Without the right design, right data and right decisions, idealised clinical trial plans cannot be translated into blueprints

X
How to craft responsive clinical trials that are designed for success
https://pharmaphorum.com/r-d/how-to-craft-responsive-clinical-trials-that-are-designed-for-success/
blockchain

Debates & Insight/ Debates & Insight/ Debates & Insights/ Digital/ Insights/ Insights/ Insights/ Patients/ R&D/ White Papers/ Whitepapers

Understanding blockchain – a practical guide for life sciences companies

, , , 0 Comment

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X
Understanding blockchain – a practical guide for life sciences companies
https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
P_and_MA_IMG_840x470

Insights/ Insights/ Market Access/ Pharma Market Access/ R&D/ Slider in whitepapers/ White Papers/ Whitepapers

Pricing and market access – facts versus fiction

0 Comment

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

X
Pricing and market access – facts versus fiction
https://pharmaphorum.com/whitepapers/pricing-market-access-facts-versus-fiction/
digital_ecosystem_west

Healthcare/ Insights/ Insights/ Patients/ R&D/ White Papers/ Whitepapers

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

0 Comment

  Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine

X
An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment
https://pharmaphorum.com/whitepapers/an-integrated-digital-ecosystem-to-support-patient-outcomes-health-system-sustainability-and-return-on-investment/
1 2

Login

CONTINUE TO SITE >
X
Close in 10 seconds